PETQ - PetIQ, Inc.
IEX Last Trade
30.57
0.050 0.164%
Share volume: 300,275
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Drugs and Druggists' Sundries Merchant Wholesalers :
-4.55%
PREVIOUS CLOSE
CHG
CHG%
$30.52
0.05
0.16%
Fundamental analysis
64%
Profitability
59%
Dept financing
36%
Liquidity
75%
Performance
74%
Performance
5 Days
0.10%
1 Month
42.29%
3 Months
48.52%
6 Months
66.76%
1 Year
56.51%
2 Year
206.11%
Key data
Stock price
$30.57
DAY RANGE
N/A - N/A
52 WEEK RANGE
$15.09 - $30.68
52 WEEK CHANGE
$0.60
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: McCord Christensen
Region: US
Website: petiq.com
Employees: 1,890
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Drugs and Druggists' Sundries Merchant Wholesalers
Sector: Wholesale Trade
Region: US
Website: petiq.com
Employees: 1,890
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Drugs and Druggists' Sundries Merchant Wholesalers
Sector: Wholesale Trade
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels.
Recent news